Rigel Pharmaceuticals Inc (RIGL)

Cost of Revenue

$23.84M

TTM · Period ending: · USD

RIGL logo

RIGL Cost of Revenue

Latest reported$23.84M
RIGL TTM Cost of Revenue ($0.00 → $23.84M)
High-resolution chart · PNG

RIGL cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Rigel Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
-817,000
-817,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.